Aflibercept versus placebo in combination with fluorouracil, leucovorin and irinotecan in the treatment of previously treated metastatic colorectal cancer: prespecified subgroup analyses from the VELOUR trial. (Q54401988)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Aflibercept versus placebo in combination with fluorouracil, leucovorin and irinotecan in the treatment of previously treated metastatic colorectal cancer: prespecified subgroup analyses from the VELOUR trial. |
scientific article |
Statements
Aflibercept versus placebo in combination with fluorouracil, leucovorin and irinotecan in the treatment of previously treated metastatic colorectal cancer: prespecified subgroup analyses from the VELOUR trial. (English)
Eric Van Cutsem
Radek Lakomý
Jana Prausová
Paul Ruff
Guy A van Hazel
David R Ferry
Joseph J McKendrick
Karen Soussan-Lazard
Soazig Chevalier
Carmen J Allegra
16 October 2013
50
2
320-331